Investment Criteria

We are focusing on the following investment opportunities.

Investment Sectors:

• Drug Discovery (First-in-class or new biology-based approach)
• Innovative Platform Technologies for Drug Discovery
• Spin-out Opportunities from Taiho Pipelines
• Medical Device/Diagnostics/Digital Health (opportunistic)

Therapeutic areas:

• Oncology
• “Non-oncology” (Immunology/Allergy/Bone/Muscle/Orphan)

Modality:

• Small Molecules
• Biologics
• Gene/Cell Therapy

Stage:

• Research to Pre-IND
• IND to PoC (opportunistic)